Malignancy during pregnancy is a rare clinical entity, complicating approximately 1 in 1000 to 1 in 2000 pregnancies overall. [1][2][3] Previous studies related to pregnancy with malignancy primarily focused on optimizing anti-cancer treatment during pregnancy and examining the fetal effects of such therapy, 1,2,4 and limited data are available regarding the psychological effect of malignancy among pregnant women. For instance, a 2019 systematic review identified only a few studies that reported the psychological aspects of pregnant women with malignancy, 5-9 and these previous investigations have been limited by their small heterogeneous study size. [5][6][7][8][9] The risk of psychological comorbidities such as anxiety or depressive disorder is likely higher as pregnant women who have cancer face two major life events: a life-threatening cancer diagnosis and the pregnancy itself. [6][7][8][9] These two life events are conflicting for the patients, and a challenging and devastating event such as cancer during pregnancy can trigger fear, guilt, and anxiety in the patient. 4 Given the rarity of pregnancy with malignancy, a large-scale analysis of psychological comorbidities can provide valuable clinical